ストックスクリーナーアプリを入手
3.3661
2.43%
-0.0839
Aclarion Inc (ACON) 最新ニュース
Macro Review: Should I hold or sell Aclarion Inc Equity Warrant now2026 Price Swings & Fast Moving Market Watchlists - baoquankhu1.vn
Echo Lake Capital Calls for the Resignation of David Neal From the Board of Directors of Aclarion Inc. - Bitget
Investment Review: Is Aclarion Inc. still a buy after recent gains2026 Review & Stepwise Trade Signal Guides - baoquankhu1.vn
Targets Report: Is Aclarion Inc still a buy after recent gainsPortfolio Update Summary & Scalable Portfolio Growth Ideas - baoquankhu1.vn
Aclarion, Inc. Adopts One-Year Stockholder Rights Plan to Protect Shareholder Value and Prevent Hostile Takeovers - Minichart
Aclarion adopts one-year stockholder rights plan By Investing.com - Investing.com India
Aclarion Adopts One-Year Stockholder Rights Protection Plan - TipRanks
Aclarion (NASDAQ: ACON) sets 10% trigger in one-year rights plan - Stock Titan
Aclarion adopts one-year stockholder rights plan - Investing.com
Aclarion, Inc. Adopts Limited Duration Stockholder Rights Plan - Yahoo Finance
Shareholder Letter From Chief Executive Officer Brent Ness - 富途牛牛
Aclarion, Inc. Pursues Insurance Reimbursement Initiatives and Reports Strong Momentum Leading into 2026 - Quiver Quantitative
Aclarion Publishes CEO Shareholder Letter Highlighting Strategic Progress and 2026 Catalysts - Bluefield Daily Telegraph
Aclarion targets US insurers as back-pain trial readout nears - Stock Titan
Aclarion : Shareholder Letter from Chief Executive Officer Brent Ness - marketscreener.com
Aclarion, Inc. Revolutionizes Low Back Pain Diagnosis with MR Spectroscopy and AI-Powered NOCISCAN Platform 798083 - Minichart
Published on: 2026-03-19 07:53:44 - baoquankhu1.vn
Aclarion (NASDAQ: ACON) expands NOCISCAN spine diagnostics and AI plans - Stock Titan
Aclarion 10-K: Revenue $0.076M, EPS (13.61) — Annual Report Highlights - TradingView
ACON: Revenue up 65.6% to $75.7K; net loss $7.2M; $22.6M raised in 2025, $10.4M in 2026 - TradingView
Aclarion, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com
Published on: 2026-03-19 06:54:42 - baoquankhu1.vn
Aclarion to Present at ROTH Conference, Showcasing Nociscan Technology for Chronic Back Pain Diagnosis - citybuzz -
Is Aclarion Inc Equity Warrant still a buy after recent gainsQuarterly Profit Report & Safe Entry Trade Reports - baoquankhu1.vn
Aclarion, Inc. to Engage with Investors at the 38th Annual ROTH Conference Regarding Nociscan Advancements - Quiver Quantitative
Aclarion to Participate in the 38th Annual ROTH Conference, Highlighting Key 2026 Catalysts and Strong Balance Sheet - Bitget
Back pain scan firm Aclarion meets investors at ROTH with no debt - Stock Titan
Investment Review: Whats the outlook for Aclarion Inc Equity Warrants sectorWeekly Market Summary & Daily Technical Stock Forecast Reports - baoquankhu1.vn
Aug Shorts: Is Aclarion Inc Equity Warrant benefiting from interest rate changes2026 Technical Overview & Consistent Profit Alerts - baoquankhu1.vn
Aclarion CEO to Present AI-Powered Back Pain Diagnostic Technology at Leading MedTech Conference - citybuzz -
Aclarion CEO Brent Ness to Attend LSI USA 2026 - Bitget
Aclarion, Inc. CEO Brent Ness to Attend LSI USA 2026 to Discuss NOCISCAN and Industry Partnerships - Quiver Quantitative
Back pain imaging firm Aclarion courts partners at LSI USA 2026 - Stock Titan
Quarterly Risk: Is Aclarion Inc Equity Warrant stock undervalued right nowQuarterly Profit Review & Free High Accuracy Swing Entry Alerts - baoquankhu1.vn
Decliners Report: Is Aclarion Inc Equity Warrant attractive for institutional investorsTrade Volume Report & Growth-Oriented Investment Plans - baoquankhu1.vn
What is Aclarion Inc Equity Warrants 5 year growth outlookJuly 2025 Spike Watch & High Accuracy Swing Entry Alerts - baoquankhu1.vn
Will Aclarion Inc. stock benefit from upcoming earnings reports2026 Chart Watch & Proven Capital Preservation Methods - Naître et grandir
Aug EndMonth: How Aclarion Inc. Equity Warrant stock reacts to job market dataTrade Analysis Report & Accurate Buy Signal Notifications - Naître et grandir
Dividend Watch: Will Aclarion Inc Equity Warrant outperform during market rallies2025 Analyst Calls & Breakout Confirmation Alerts - baoquankhu1.vn
Analyst Calls: Will Aclarion Inc Equity Warrant outperform during market ralliesIndex Update & Consistent Return Strategy Ideas - baoquankhu1.vn
Bank Watch: Does Five Below Inc stock have upside surprise potentialMarket Activity Recap & Safe Entry Momentum Tips - baoquankhu1.vn
Retail Trends: Whats next for CalciMedica Inc stock2025 Sector Review & Technical Entry and Exit Tips - baoquankhu1.vn
ACON PE Ratio & Valuation, Is ACON Overvalued - Intellectia AI
Activity Recap: Is Tidewater Inc forming a breakout patternWeekly Market Outlook & Weekly Top Stock Performers List - baoquankhu1.vn
ACON Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Volatility Watch: Is Aclarion Inc still a buy after recent gainsTrade Risk Summary & High Return Stock Watch Alerts - baoquankhu1.vn
Trading Recap: Whats the outlook for Aclarion Inc Equity Warrants sectorJuly 2025 Summary & Fast Exit/Entry Strategy Plans - baoquankhu1.vn
Investor Mood: Is Aclarion Inc Equity Warrant still a buy after recent gains - baoquankhu1.vn
Market Wrap: Is Aclarion Inc Equity Warrant stock undervalued right now2025 Big Picture & Reliable Entry Point Trade Alerts - baoquankhu1.vn
Can Aclarion Inc. Equity Warrant stock continue upward trend2025 Key Lessons & Safe Entry Momentum Stock Tips - mfd.ru
US Market Wrap: Should I hold or sell Aclarion Inc. Equity Warrant now2025 Short Interest & Stepwise Entry and Exit Trade Signals - mfd.ru
Is Aclarion Inc. stock positioned for long term growthWeekly Earnings Recap & Consistent Income Trade Ideas - mfd.ru
ACON Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
ACON Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
Can Aclarion Inc. weather a recessionNew Guidance & Verified Stock Trade Ideas - mfd.ru
What are Aclarion Inc.’s earnings expectationsWeekly Stock Report & Reliable Price Action Trade Plans - mfd.ru
Earnings Beat: Is TriSalus Life Sciences Inc Equity Warrant a strong growth stock2025 Growth vs Value & Short-Term Trading Alerts - baoquankhu1.vn
What’s the outlook for Aclarion Inc. Equity Warrant’s sectorWeekly Investment Report & Low Drawdown Trading Strategies - mfd.ru
NeuroOne Medical Technologies (NASDAQ:NMTC) versus Aclarion (NASDAQ:ACON) Head to Head Contrast - Defense World
How does Aclarion Inc. Equity Warrant correlate with NasdaqWeekly Investment Summary & Daily Chart Pattern Signals - mfd.ru
0.57%
1.91%
大文字化:
|
ボリューム (24 時間):